首页> 外国专利> PARASPECKLE COMPONENT 1 (PSPC1) PROMOTING EPITHELIAL-MESENCHYMAL TRANSITION, STEMNESS AND METASTASIS AS AN ANTI-CANCER TARGET

PARASPECKLE COMPONENT 1 (PSPC1) PROMOTING EPITHELIAL-MESENCHYMAL TRANSITION, STEMNESS AND METASTASIS AS AN ANTI-CANCER TARGET

机译:paraSpeckle组分1(pspc1)促进上皮 - 间充质转变,茎和转移作为抗癌目标

摘要

An isolated nucleic acid encoding a C-terminal fragment of paraspeckle component 1 (PSPC1) is disclosed. The C-terminal fragment of the PSPC1 comprises an extension of more than 10 but no greater than 131 amino acid residues with its C-terminal amino acid identical to the C-terminus of the PSPC1 sequence SEQ ID NO: 3 and exhibits a biological activity against tumor cells. The tumor cells are associated with either PSPC1 or protein tyrosine kinase 6 (PTK6), or both. The anti-tumor activity is at least one selected from the group consisting of: (a) suppressing tumor cell growth; (b) suppressing tumor cell progression; (c) suppressing tumor cell metastasis; (d) decreasing PSPC1 expression; and (e) decreasing oncogenic PTK6 expression in cytoplasm. Also disclosed is a peptide comprising a C-terminal fragment sequence of PSPC1. A reagent kit and method for predicting tumor progression, metastasis, and prognosis in a cancer patient are also disclosed.
机译:公开了编码ParaSpecle组分1(PSPC1)的C末端片段的分离的核酸。 PSPC1的C-末端片段包括大于10但不大于131个氨基酸残基的延伸,其C-末端氨基酸与PSPC1序列SEQ ID NO:3的C-末端相同,并表现出生物活性针对肿瘤细胞。肿瘤细胞与PSPC1或蛋白酪氨酸激酶6(PTK6)或两者有关。抗肿瘤活性至少是选自:(a)抑制肿瘤细胞生长; (b)抑制肿瘤细胞进展; (c)抑制肿瘤细胞转移; (d)减少PSPC1表达; (e)减少细胞质中的致癌PTK6表达。还公开了包含PSPC1的C-末端片段序列的肽。还公开了一种试剂盒和用于预测肿瘤进展,转移和预后的方法。

著录项

  • 公开/公告号US2021087239A1

    专利类型

  • 公开/公告日2021-03-25

    原文格式PDF

  • 申请/专利权人 ACADEMIA SINICA;

    申请/专利号US202016970350

  • 发明设计人 YUH-SHAN JOU;YAW-DONG LANG;HSI-WEN YEH;

    申请日2020-02-12

  • 分类号C07K14/47;C12N15/63;

  • 国家 US

  • 入库时间 2022-08-24 17:54:45

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号